Join the Birth Control group to help and get support from people like you.
Birth Control News (Page 6)
Related terms: Fertility Control, Anticonception
FDA Approves Extension of Mirena (levonorgestrel-releasing intrauterine system) Intrauterine Device (IUD) for up to Eight Years of Pregnancy Prevention
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a leader in women's healthcare, announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that...
FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control
GREENVILLE, N.C., April 16, 2021 /PRNewswire/ – Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Nextstellis (3 mg drospirenone [DRSP] and 14.2 mg estetrol...
FDA Approves Phexxi (lactic acid, citric acid and potassium bitartrate) Non-Hormonal Prescription Gel for the Prevention of Pregnancy
SAN DIEGO, May 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and pota...
FDA Approves Twirla (levonorgestrel and ethinyl estradiol) Contraceptive Patch
PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) – Agile Therapeutics, Inc., (Nasdaq: AGRX) (Agile or the Company), a forward-thinking women’s healthcare company, today announced that the U.S. Food a...
FDA Approves EluRyng (etonogestrel/ethinyl estradiol vaginal ring), the First Generic NuvaRing
BRIDGEWATER, N.J.--(BUSINESS WIRE) December 12, 2019 – Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (AND...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Six Years
SAN FRANCISCO and DUBLIN October 28, 2019 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, and Allergan plc (NYSE: AGN), a leading global p...
Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24/4 Dosing Regimen and 24-hour Missed Pill Window
FLORHAM PARK, N.J., June 6, 2019 /PRNewswire/ – Exeltis USA, Inc. a division of the global pharmaceutical group Insud Pharma, announced today that the US Food and Drug Administration (FDA) has...
FDA Medwatch Alert: Janssen Issues Voluntary Nationwide Recall for One Lot of Ortho-Novum 1/35 and Two Lots of Ortho-Novum 7/7/7 Due to Incorrect Veridate Dispenser Instructions
The Ortho-Novum® product itself remains safe and effective for use with the appropriate dispenser instructionsTITUSVILLE, NJ – November 2, 2018 – Janssen Pharmaceuticals, Inc. has initiated a vo...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Five Years
DUBLIN and SAN FRANCISCO October 16, 2018 – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company with a mis...
FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System
NEW YORK, Aug. 10, 2018 /PRNewswire/ – The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera™ (...
FDA Medwatch Alert: Taytulla (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) by Allergan: Recall - Due to Out of Sequence Capsules
ISSUE: Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of Taytulla and the first four days of therapy had four...
FDA Medwatch Alert: Essure Permanent Birth Control System by Bayer Healthcare: Announcement - FDA Restricts the Sale and Distribution
ISSUE: The FDA is aware that some women have received the Essure device without being adequately informed of Essure’s risks. In order for this device to meet reasonable assurance of safety and e...
Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive
ATLANTA, Jan. 17, 2018 /PRNewswire/ – Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral ...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Four Years
August 6, 2017 – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to...
FDA Medwatch Alert: Mibelas 24 Fe Chewable Tablets by Lupin Pharmaceuticals Inc.: Recall - Out of Sequence Tablets and Missing Expiry/Lot Information
ISSUE: Lupin Pharmaceuticals Inc. announced a recall of lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg) Tablets ...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Emergency Contraception, Postcoital Contraception
Related drug support groups
Depo-Provera, Nexplanon, Provera, NuvaRing, Mirena, Implanon, levonorgestrel, Sprintec, Loestrin 24 Fe, Yasmin, Lo Loestrin Fe, medroxyprogesterone, Kyleena